Evidence map›Paper›PMID 36387163›Full record

ArticleFrontiers in oncology2022

An analysis of sexual dimorphism in the tumor microenvironment of colorectal cancer.

Andrea E Geddes, Anita L Ray, Robert A Nofchissey, Azadeh Esmaeili, Apryl Saunders, Dawn E Bender, Maaz Khan, Sheeja Aravindan, Jared T Ahrendsen, Min Li and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Sex Differences in Colorectal Tumor-Associated T-cell Responses.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Gender and sex differences in colorectal cancer screening, diagnosis and treatment.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Andrea E GeddesDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Anita L RayDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Robert A NofchisseyDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Azadeh EsmaeiliDepartment of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Apryl SaundersDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Dawn E BenderDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Maaz KhanDepartment of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Sheeja AravindanUniversity of Oklahoma Health Science Center, Stephenson Cancer Center, Oklahoma City, OK, United States.
Jared T AhrendsenDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Min LiDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Kar-Ming FungDepartment of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Muralidharan JayaramanUniversity of Oklahoma Health Science Center, Stephenson Cancer Center, Oklahoma City, OK, United States.
Jingxuan YangDepartment of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Kristina K BoothDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Gary D DunnDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Steven N CarterDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Katherine T MorrisDepartment of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
University of Oklahoma Health Sciences Center · USOU Health Stephenson Cancer CenterHarvard University · US

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Wade Williams · 2018 to 2026
$27.1M
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DHANASEKARAN, DANNY N. · 2012 to 2022
$21.3M
NCI NIH HHS P30 CA225520NIGMS NIH HHS P20 GM103639
6 · The paper itself

Abstract

Women with colorectal cancer (CRC) have survival advantages over men, yet the underlying mechanisms are unclear. T cell infiltration within the CRC tumor microenvironment (TME) correlates strongly with survival. We hypothesized that women with CRC have increased T cell infiltration and differential gene expression in the TME compared to men. Tissue microarrays comprising primary tumor, tumor infiltrated lymph nodes, and uninvolved colon were created from CRC patients. Proportions of CD4 positive (CD4+) and CD8 positive (CD8+) T cells were identified using immunohistochemistry. TME immune- and cancer-related genetic expression from primary and metastatic CRC tumor were also evaluated

Indexed as

colorectal cancerimmunoscoresexual dimorphismT celltumor microenvironment

Identifiers

PMID36387163
PMCPMC9651089
OpenAlexW4307703266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.